Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A trial with a new peripheral implanted vascular access device.

V Winters1, B Peters, S Coilá

  • 1Comprehensive Cancer Center, Good Samaritan Hospital & Medical Center, Portland, OR.

Oncology Nursing Forum
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermittent Fasting Regimes Reduce Gingival Inflammation: A Three-Arm Clinical Trial.

Journal of clinical periodontology·2025
Same author

Is mapping the BCG vaccine-induced immune responses the key to improving the efficacy against tuberculosis?

Journal of internal medicine·2020
Same author

Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients.

Pediatric cardiology·2020
Same author

[A boy with white sponge naevus of the buccal mucosa].

Nederlands tijdschrift voor geneeskunde·2020
Same author

Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Pear-Shaped Lesion of the Fossa of Rosenmüller.

Journal of the Belgian Society of Radiology·2018

A new peripheral vascular access device, the Port-A-Cath P.A.S. Port, shows promising results for long-term venous access in patients needing various therapies. Complication rates were manageable, with no infiltrations or extravasations reported.

Area of Science:

  • Vascular Surgery
  • Medical Devices
  • Patient Care

Background:

  • Long-term venous access is crucial for various medical therapies.
  • Traditional central venous access ports have associated risks and limitations.
  • Peripheral venous access offers a potentially less invasive alternative.

Purpose of the Study:

  • To evaluate the safety and efficacy of a novel peripherally placed vascular access device.
  • To assess complication rates and patient acceptance of the Port-A-Cath P.A.S. Port.
  • To compare the performance of peripheral ports with standard central venous ports.

Main Methods:

  • A prospective study evaluated 32 patients over 13 months.
  • The Port-A-Cath P.A.S. Port was implanted for long-term venous access.

Related Experiment Videos

  • Data collected included patient demographics, therapies administered, and complications.

    • Main Results:

    • 19 complications occurred in 14 patients over 4,896 patient days (3.88/1,000 catheter days).
    • Infection and port pocket cellulitis rates were low (3% each).
    • Vein phlebitis (12.5%), vessel thrombosis (6.2%), and inability to aspirate blood (18.75%) were the main complications. No infiltrations or extravasations occurred.

    Conclusions:

    • The Port-A-Cath P.A.S. Port is a viable option for long-term peripheral venous access.
    • Complication rates are comparable to standard central venous ports, with specific challenges like aspiration difficulties noted.
    • Patients and nurses found the peripheral port placement well-accepted and similar in performance to traditional chest ports.